Bio-Path Holdings (BPTH) 的表现优于 Generation Bio (GBIO)，其收益更高、波动性更低、且潜在上涨空间更大。 Bio-Path Holdings (BPTH) outperforms Generation Bio (GBIO) with higher earnings, lower volatility, and higher potential upside.

由于收益更高、波动性更低，Bio-Path Holdings (BPTH) 被认为是比 Generation Bio (GBIO) 更优的股票选择。 Bio-Path Holdings (BPTH) is considered the superior stock choice over Generation Bio (GBIO) due to higher earnings and lower volatility. Bio-Path 的贝塔值为 0.28（波动性比标准普尔 500 指数低 72%），而 GBIO 的贝塔值为 2.83。 Bio-Path has a beta of 0.28 (72% less volatile than S&P 500) compared to GBIO's 2.83. Bio-Path 的机构持股比例 (5.7%) 明显低于 GBIO (95.2%)。 Institutional ownership is significantly lower for Bio-Path (5.7%) than GBIO (95.2%). Bio-Path 的一致目标价为 20.00 美元，表明潜在的上涨空间为 920.41%，而 GBIO 的目标价为 8.00 美元，表明潜在的上涨空间为 193.04%。 Bio-Path's consensus price target of $20.00 suggests a potential upside of 920.41%, compared to GBIO's $8.00 target, indicating a 193.04% potential upside.